Lumos Pharma Inc. buy DomRuinart
Start price
11.01.21
/
50%
€18.00
Target price
11.01.22
€25.00
Performance (%)
-17.22%
End price
25.01.21
€14.90
Summary
This prediction ended on 25.01.21 with a price of €14.90. The prediction for Lumos Pharma Inc. disappointed with a performance of -17.22%. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Lumos Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% | 64.548% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% | 110.363% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% | 55.210% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% | 70.174% |
According to DomRuinart what are the pros and cons of Lumos Pharma Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread NewLink Genetics Corp diskutieren
Buy mit Kursziel 25,0